Liposomes loaded with a dirhenium compound and cisplatin: preparation, properties and improved in vivo anticancer activity. (Q38958186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Liposomes loaded with a dirhenium compound and cisplatin: preparation, properties and improved in vivo anticancer activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Nataliia I Shtemenko

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Dina Y Yegorova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Svetlana O Babiy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Andrew J Brown

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Tinglu Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Alexander V Shtemenko

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Kim R Dunbar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

9 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

Journal of Liposome Research

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

78-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

Formation of transition metal-doxorubicin complexes inside liposomes

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Coencapsulation of arsenic- and platinum-based drugs for targeted cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Antitumour metal compounds: more than theme and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Cisplatin interaction with phosphatidylserine bilayer studied by solid-state NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Anticancer cisplatin interactions with bilayers of total lipid extract from pig brain: A13C, 31P and 15N solid-state NMR study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Systematic prioritization of cancer combination therapies: are we really on target?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Mechanisms of Cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Cytotoxic chemotherapy for differentiated thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Synthesis, characterization, in vivo antitumor properties of the cluster rhenium compound with GABA ligands and its synergism with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Synthesis, X-ray structure, interactions with DNA, remarkable in vivo tumor growth suppression and nephroprotective activity of cis-tetrachloro-dipivalato dirhenium(III).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Liposomal forms of rhenium cluster compounds: enhancement of biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Liposomal cisplatin: a new cisplatin formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.954127

10.3109/08982104.2014.954127

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25203608%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference